Nebulised Heparin to Reduce COVID-19 Induced Acute Lung Injury
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- ARDS, Human
- COVID-19
- Lung Injury, Acute
- Ventilation Perfusion Mismatch
- Type
- Interventional
- Phase
- Phase 1Phase 2
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT04511923
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: John Laffey Professor of Anaesthesia and Intensive Care Medicine, National University of Ireland, Galway, Ireland
Get Well Soon